Evaluation of Cytocompatibility of Bioglass-Niobium Granules with Human Primary Osteoblasts: A Multiparametric Approach

Abstract:

The pursuit for an ideal bone substitute remains the main focus of many tissue engineering researchers. Among the myriad types of grafts available, synthetic bone grafts are of special importance, because it is available in large amounts, reduce the surgical trauma and eliminate the risk of diseases’ transmission. In this context, bioactive glasses have received attention mostly due to its described biocompatibility and rapid rate of surface reactivity when compared with other materials, allowing for faster interactions with the local tissue. The addition of niobium to this material has been shown as increasing the chemical resistance of the compound and providing greater stability. However, alterations on the chemical composition of biomaterials may impact on its biocompatibility. Therefore, the aim of this study was to evaluate the in vitro biocompatibility of bioglass-Niobium (BgNb) granules, in comparison with standard commercial bioglass (Biogran®) throughout an interesting multiparametrical approach, employing Phenol 2% and dense polystyrene beads as positive and negative controls, respectively. Extracts from each material were prepared by 24 hours incubation in culture medium (DMEM). Human primary osteoblasts were then exposed for 24 hours to each extract and cell viability was evaluated by three parameters: mitochondrial activity (XTT method), membrane integrity (neutral red dye uptake) and cell density (crystal violet dye exclusion test). BgNb extracts were highly compatible, since the levels of viable cells were similar to the control group (unexposed cells), on all parameters studied. The mean cell density on the Biogran® group was slightly lower than BgNb, even though this material was also non-cytotoxic. The excellent in vitro response for BgNb granules indicates the suitability of this material to future studies on its biological and physical properties when applied in vivo.

• Periodical: Key Engineering Materials (Volumes 493-494)
• Pages: 37-42
• DOI: https://doi.org/10.4028/www.scientific.net/KEM.493-494.37
• Online since: October 2011
• Authors: G.V.O. Fernandes, Gutemberg Alves, A.B.R. Linhares, Marcelo Henrique Prado da Silva, J.M. Granjeiro
• Keywords: Biocompatibility, Bioglass, Niobium

References

[1] Williams DF, Dictionary of biomaterials. 1ed., Liverpool, Liverpool University Press, (1999).

[2] Anselme K, Osteoblast adhesion on biomaterials. Biomaterials. 21 (2000) 667-681.

DOI: 10.1016/s0142-9612(99)00242-2

[3] Hulbert SF, Cooke FW. Attachment of prosthesis to the musculo-skeletal system by tissue ingrowth and mechanical interlocking. Biom. Mat. Symp. 4 (1970) 1-23.

[4] Hench LL, Jones JR, Biomaterials, artificial organs and tissue engineering. Woodhead Publishing Limited, USA, (2008).

[5] Piattelli G, Scarano A, Piattelli M, Coraggio F, Matarasso S, Bone regeneration using Bioglass: an experimental study in rabbit tibia. J. Oral Implantol. 26 (2000) 257-261.

DOI: 10.1563/1548-1336(2000)026<0257:brubae>2.3.co;2

[6] Oonishi H, Hench LL, Wilson J, Sugihara F, Tsuji E, Kushitani S, Iwaki H, Comparative bone growth behavior in granules of bioceramic materials of various sizes. J. Biomed. Mater. Res. 44 (1999) 31-43.

DOI: 10.1002/(sici)1097-4636(199901)44:1<31::aid-jbm4>3.0.co;2-9

[7] Prado da Silva, MH, Ramirez CM, Granjeiro JM, Rossi AM, In vitro assessment of new Niobium Phosphate Glasses and Glass Ceramics. Key Eng. Mat. 361-363 (2008) 229-232.

DOI: 10.4028/www.scientific.net/kem.361-363.229

[8] Tamai M, Isama K, Nakaoka R, Tsuchiya T, Synthesis of a novel b-tricalcium phosphate/hydroxyapatite biphasic calcium phosphate containing niobium ions and evaluation of its osteogenic properties. J. Art. Org. 10 (2007) 22-28.

DOI: 10.1007/s10047-006-0363-y

[9] Sene FF, Martinelli JR, Gomes L, Synthesis and characterization of niobium phosphate glasses containing barium and potassium. J. Non-Crystalline Solids 348 (2004) 30–37.

DOI: 10.1016/j.jnoncrysol.2004.08.122

[10] ISO 10993-5, Biological evaluation of medical devices. Part 5: Tests for cytotoxicity: In vitro methods, International Organization for Standardization, Geneva (2009).

DOI: 10.2345/9781570203558.ch1

[11] De Deus G, Canabarro A, Alves G, Linhares A, Senne MI, Granjeiro JM, Optimal cytocompatibility of a bioceramic nanoparticulate cement in primary human mesenchymal cells. J. Endod. 35 (2009) 1387-90.

DOI: 10.1016/j.joen.2009.06.022

[12] Amaral M, Lopes MA, Silva RF, Santos JD, Densification route of Si3N4 - bioglass biocomposites. Biomaterials. 23 (2002) 857-862.

DOI: 10.1016/s0142-9612(01)00194-6

[13] Oonishi H, Kushitani S, Yasukawa E, Iwaki H, Hench LL, Wilson J, Particulate bioglass compared with hydroxyapatite as a bone graft substitute. Clin. Orthop. Rel. Res. (1997) 316-325.

DOI: 10.1097/00003086-199701000-00041

[14] Macedo NL, Matuda FS, Macedo LGS, Gonzalez MB, Ouchi SM, Carvalho YR, Bone defect regeneration with bioactive glass implantation in rats, J. Appl. Oral Sci., 12 (2004) 137-43.

DOI: 10.1590/s1678-77572004000200011

[15] Spielmann H, Hoffmann S, Liebsch M, Botham P, Fentem JH, Eskes C, et al, The ECVAM international validation study on in vitro tests for acute skin irritation: report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test. Altern. Lab. Anim. 35 (2007).

DOI: 10.1177/026119290703500614